Short answer

India is considered the pharma king due to its large-scale production of affordable generic drugs and vaccines. It supplies a major share of global vaccine demand and exports medicines widely.

Key points

  • India produces over half of the world’s vaccine supply.
  • Indian generics are exported to more than 200 countries.
  • Companies like Serum Institute and Cipla are global leaders in affordable medicine.
  • The country combines skilled labor, strong infrastructure, and regulatory expertise in pharma.

India is widely regarded as the pharma king, leading global production of low-cost, high-quality generic medicines and vaccines. Its pharmaceutical industry supplies essential drugs to countries across all continents, especially in regions where affordability is critical.

Global reach of Indian medicines

Indian manufacturers meet a significant portion of global vaccine demand, including major contributions to polio eradication and routine immunization programs. During the pandemic, the Serum Institute of India produced billions of doses of the AstraZeneca vaccine, many delivered through international initiatives like COVAX.

Companies such as Cipla, Sun Pharma, and Dr. Reddy’s have built reputations for meeting international quality standards while keeping prices low. Their ability to navigate complex regulatory environments allows them to export generics widely, particularly to Africa, Asia, and Latin America.

Frequently asked questions

Why is India called the pharmacy of the world?

India is called the pharmacy of the world because it produces a large share of affordable generic medicines and vaccines used globally, especially in developing countries.

Which Indian companies are major global pharma players?

Sun Pharma, Cipla, Dr. Reddy’s, and the Serum Institute of India are among the leading companies exporting medicines and vaccines worldwide.

How does India make medicines so affordably?

India benefits from a skilled workforce, established manufacturing infrastructure, and expertise in reverse-engineering patented drugs once licenses expire.

See also

In-depth articles

Related topics